My Account Log in

1 option

Radiopharmaceuticals for sentinel lymph node detection : status and trends / International Atomic Energy Agency.

Ebook Central Academic Complete Available online

View online
Format:
Book
Author/Creator:
International Atomic Energy Agency.
Series:
IAEA radioisotopes and radiopharmaceuticals series ; Number 6.
IAEA Radioisotopes and Radiopharmaceuticals Series, 2077-6462 ; Number 6
Language:
English
Subjects (All):
Radioactive tracers.
Lymph nodes--Biopsy.
Lymph nodes.
Cancer--Diagnosis.
Cancer.
Physical Description:
1 online resource (179 pages) : illustrations (some color).
Edition:
1st ed.
Place of Publication:
Vienna, [Austria] : International Atomic Energy Agency, 2015.
Summary:
This book summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma. The publication covers all current aspects of this diagnostic methodology, including the production of nanocolloidal particles, their biological mechanism of action and relevant clinical applications. It also illustrates the recent developments in the field fuelled by the introduction of molecular imaging agents for SLND and of multimodality optical and radioactive agents. Included in the results presented in this book, are those on the novel generation of SLND radiopharmaceuticals obtained through an IAEA Coordinated Research Project.
Notes:
Description based on online resource; title from PDF title page (ebrary, viewed June 2, 2017).
ISBN:
92-0-118819-6
OCLC:
987091972

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account